High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$104M
$104,269,302
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IONS
M
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
Other
2026-03-10
$1,665,128Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
Other
|
2026-03-10 | $1,665,128Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
2026-03-10
$2,827,325Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
|
2026-03-10 | $2,827,325Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-10 | $2,076,532Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $2,589,144Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $6,962,832Whalex2 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $9,525,011Whalex3 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -14.0%
2026-03-09
$763,662
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -14.0%
|
2026-03-09 | $763,662 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Other
2026-03-04
$20,066x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Other
|
2026-03-04 | $20,066x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2026-03-04
$35,120x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2026-03-04 | $35,120x2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-04 | $7,612 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-04 | $16,000 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Other
2026-03-03
$75,215x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Other
|
2026-03-03 | $75,215x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2026-03-03
$495,867x3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2026-03-03 | $495,867x3 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
Other
2026-03-03
$3,497,531Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
Other
|
2026-03-03 | $3,497,531Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
10b5-1 Sell
2026-03-03
$6,741,669Whalex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
10b5-1 Sell
|
2026-03-03 | $6,741,669Whalex3 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
Other
2026-03-03
$723,254x5
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
Other
|
2026-03-03 | $723,254x5 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
10b5-1 Sell
2026-03-03
$1,596,433Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
10b5-1 Sell
|
2026-03-03 | $1,596,433Largex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $1,601,607Largex3 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Diaz Allene M.
• Director
10b5-1 SellΔOwn -20.9%
2026-03-03
$4,354,428Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -20.9%
|
2026-03-03 | $4,354,428Largex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $652,120x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
KLEIN JOSEPH III
• Director
10b5-1 Sell
2026-03-03
$1,696,181Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-03 | $1,696,181Largex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $31,666 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-03 | $66,833 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
10b5-1 SellΔOwn -16.2%
2026-02-13
$1,278,914Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
10b5-1 SellΔOwn -16.2%
|
2026-02-13 | $1,278,914Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-11 | $413,588 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Monia Brett P
• CEO
10b5-1 SellΔOwn -10.4%
2026-02-06
$2,524,820Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 SellΔOwn -10.4%
|
2026-02-06 | $2,524,820Large | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
Other
2026-02-02
$3,497,531Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
Other
|
2026-02-02 | $3,497,531Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -17.0%
2026-02-02
$7,056,216Whalex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -17.0%
|
2026-02-02 | $7,056,216Whalex3 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Discretionary SellΔOwn -10.4%
2026-01-30
$439,364
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Discretionary SellΔOwn -10.4%
|
2026-01-30 | $439,364 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
Discretionary Sell
2026-01-30
$488,141
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
Discretionary Sell
|
2026-01-30 | $488,141 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
Discretionary Sell
2026-01-30
$513,048
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
Discretionary Sell
|
2026-01-30 | $513,048 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2026-01-30 | $581,702 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Monia Brett P
• CEO
Discretionary SellΔOwn -18.1%
2026-01-30
$5,208,979Whale
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Discretionary SellΔOwn -18.1%
|
2026-01-30 | $5,208,979Whale | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Discretionary Sell
2026-01-30
$516,153
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Discretionary Sell
|
2026-01-30 | $516,153 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Schneider Eugene
• Officer • EVP, Chf Clinical Develop Ofcr
Discretionary Sell
2026-01-30
$515,630
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf Clinical Develop Ofcr
Discretionary Sell
|
2026-01-30 | $515,630 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
Discretionary SellΔOwn -11.5%
2026-01-30
$512,446
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
Discretionary SellΔOwn -11.5%
|
2026-01-30 | $512,446 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
10b5-1 SellΔOwn -15.0%
2026-01-22
$323,490
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
10b5-1 SellΔOwn -15.0%
|
2026-01-22 | $323,490 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Sell to CoverΔOwn -14.6%
2026-01-16
$610,276x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Sell to CoverΔOwn -14.6%
|
2026-01-16 | $610,276x2 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
Sell to Cover
2026-01-16
$674,622
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
Sell to Cover
|
2026-01-16 | $674,622 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
Sell to CoverΔOwn -12.3%
2026-01-16
$636,933
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
Sell to CoverΔOwn -12.3%
|
2026-01-16 | $636,933 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
Sell to CoverΔOwn -23.9%
2026-01-16
$634,410
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
Sell to CoverΔOwn -23.9%
|
2026-01-16 | $634,410 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Sell to Cover
|
2026-01-16 | $971,993 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
Sell to CoverΔOwn -10.0%
2026-01-16
$138,475
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
Sell to CoverΔOwn -10.0%
|
2026-01-16 | $138,475 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Kordasiewicz Holly B.
• Officer • EVP, Chief Development Officer
Sell to CoverΔOwn -22.0%
2026-01-16
$313,308
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
Sell to CoverΔOwn -22.0%
|
2026-01-16 | $313,308 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Monia Brett P
• CEO
Sell to CoverΔOwn -16.4%
2026-01-16
$3,294,624Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Sell to CoverΔOwn -16.4%
|
2026-01-16 | $3,294,624Large | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Sell to CoverΔOwn -12.2%
2026-01-16
$697,045
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Sell to CoverΔOwn -12.2%
|
2026-01-16 | $697,045 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Schneider Eugene
• Officer • EVP, Chf Clinical Develop Ofcr
Sell to CoverΔOwn -12.7%
2026-01-16
$703,138
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf Clinical Develop Ofcr
Sell to CoverΔOwn -12.7%
|
2026-01-16 | $703,138 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
Sell to CoverΔOwn -13.3%
2026-01-16
$748,383x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
Sell to CoverΔOwn -13.3%
|
2026-01-16 | $748,383x2 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
Equity Compensation
2026-01-07
$2,265,415Largex10
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
Equity Compensation
|
2026-01-07 | $2,265,415Largex10 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
10b5-1 SellΔOwn -10.7%
2026-01-07
$3,760,577Largex5
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
10b5-1 SellΔOwn -10.7%
|
2026-01-07 | $3,760,577Largex5 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
WENDER JOSEPH H
• Director
10b5-1 SellΔOwn -17.1%
2025-12-01
$2,262,848Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -17.1%
|
2025-12-01 | $2,262,848Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2025-11-19 | $2,525,400Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
HERMAN JOAN E
• Director
Discretionary SellΔOwn -20.7%
2025-11-19
$3,173,830Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Discretionary SellΔOwn -20.7%
|
2025-11-19 | $3,173,830Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2025-11-18 | $390,720 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
10b5-1 SellΔOwn -14.1%
2025-11-06
$609,379
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
10b5-1 SellΔOwn -14.1%
|
2025-11-06 | $609,379 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
Other
2025-11-06
$1,951,111Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
Other
|
2025-11-06 | $1,951,111Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
10b5-1 SellΔOwn -19.8%
2025-11-06
$2,501,725Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
10b5-1 SellΔOwn -19.8%
|
2025-11-06 | $2,501,725Largex2 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
Other
2025-11-05
$94,197x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
Other
|
2025-11-05 | $94,197x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
10b5-1 Sell
2025-11-05
$120,091x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
10b5-1 Sell
|
2025-11-05 | $120,091x2 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
Other
2025-11-03
$99,110x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
Other
|
2025-11-03 | $99,110x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
10b5-1 Sell
2025-11-03
$126,091x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
10b5-1 Sell
|
2025-11-03 | $126,091x2 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
Other
2025-10-31
$4,074,103Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
Other
|
2025-10-31 | $4,074,103Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
10b5-1 SellΔOwn -25.1%
2025-10-31
$6,703,341Whalex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
10b5-1 SellΔOwn -25.1%
|
2025-10-31 | $6,703,341Whalex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2025-10-31 | $835,520 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
LOSCALZO JOSEPH
• Director
10b5-1 SellΔOwn -30.6%
2025-10-31
$1,201,669Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -30.6%
|
2025-10-31 | $1,201,669Large | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
WENDER JOSEPH H
• Director
10b5-1 SellΔOwn -14.9%
2025-10-31
$841,776
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -14.9%
|
2025-10-31 | $841,776 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
WENDER JOSEPH H
• Director
10b5-1 Sell
2025-10-30
$1,230,801Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-30 | $1,230,801Largex3 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
Sell to Cover
2025-10-16
$92,984
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
Sell to Cover
|
2025-10-16 | $92,984 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
Sell to CoverΔOwn -17.1%
2025-10-16
$3,902
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
Sell to CoverΔOwn -17.1%
|
2025-10-16 | $3,902 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
Other
2025-10-15
$668,092
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
Other
|
2025-10-15 | $668,092 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
10b5-1 SellΔOwn -17.9%
2025-10-15
$897,398
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
10b5-1 SellΔOwn -17.9%
|
2025-10-15 | $897,398 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
Other
2025-10-15
$291,060
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
Other
|
2025-10-15 | $291,060 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
10b5-1 SellΔOwn -27.4%
2025-10-15
$437,654
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
10b5-1 SellΔOwn -27.4%
|
2025-10-15 | $437,654 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-15 | $358,722 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
Other
2025-10-14
$617,011
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
Other
|
2025-10-14 | $617,011 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Birchler Brian
• Officer • EVP, Corp and Development Ops
10b5-1 SellΔOwn -16.8%
2025-10-14
$826,589
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Corp and Development Ops
10b5-1 SellΔOwn -16.8%
|
2025-10-14 | $826,589 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2025-10-06
$112,725
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2025-10-06 | $112,725 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2025-10-06 | $30,268 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Other
2025-10-06
$539,274
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Other
|
2025-10-06 | $539,274 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 Sell
2025-10-06
$937,338x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 Sell
|
2025-10-06 | $937,338x2 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
10b5-1 SellΔOwn -18.4%
2025-10-06
$472,718
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
10b5-1 SellΔOwn -18.4%
|
2025-10-06 | $472,718 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Other
2025-10-02
$477,000
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Other
|
2025-10-02 | $477,000 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 SellΔOwn -32.0%
2025-10-02
$1,020,210Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 SellΔOwn -32.0%
|
2025-10-02 | $1,020,210Large | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Other
2025-10-02
$3,813,257Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Other
|
2025-10-02 | $3,813,257Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -34.6%
2025-10-02
$4,377,054Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -34.6%
|
2025-10-02 | $4,377,054Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
Other
|
2025-10-02 | $697,504 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
10b5-1 SellΔOwn -25.8%
2025-10-02
$859,082
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
10b5-1 SellΔOwn -25.8%
|
2025-10-02 | $859,082 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
Other
|
2025-10-01 | $760,415 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
10b5-1 SellΔOwn -27.5%
2025-10-01
$934,662
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
10b5-1 SellΔOwn -27.5%
|
2025-10-01 | $934,662 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
WENDER JOSEPH H
• Director
10b5-1 SellΔOwn -15.4%
2025-10-01
$1,100,385Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -15.4%
|
2025-10-01 | $1,100,385Large | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
Other
2025-09-30
$3,113,283Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
Other
|
2025-09-30 | $3,113,283Large | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Geary Richard S
• Officer • EVP, Chief Development Officer
10b5-1 SellΔOwn -42.1%
2025-09-30
$3,777,668Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Development Officer
10b5-1 SellΔOwn -42.1%
|
2025-09-30 | $3,777,668Large | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Other
|
2025-09-30 | $2,677,746Large | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
HOUGEN ELIZABETH L
• CFO
10b5-1 SellΔOwn -31.1%
2025-09-30
$3,249,734Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -31.1%
|
2025-09-30 | $3,249,734Large | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Other
2025-09-30
$841,877
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Other
|
2025-09-30 | $841,877 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -20.6%
2025-09-30
$958,976
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -20.6%
|
2025-09-30 | $958,976 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Other
2025-09-29
$594,657
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Other
|
2025-09-29 | $594,657 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -15.5%
2025-09-29
$675,945
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -15.5%
|
2025-09-29 | $675,945 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
Other
2025-09-12
$96,526
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
Other
|
2025-09-12 | $96,526 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 Sell
2025-09-12
$109,787
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 Sell
|
2025-09-12 | $109,787 | S | Form 4 |